nach oben

Wiener klinische Wochenschrift

Erschienen in:

01.05.2017 | case report

A patient with myasthenia gravis and a large arachnoid cyst – report of a case

verfasst von: Mira Bucuk, MD, Ph.D, Iva Gasparovic, MD, Ph.D, Ivan Sonnenschein, MD, M.Sc., Olivio Perkovic, MD, Ph.D

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 9-10/2017

Einloggen, um Zugang zu erhalten

Summary

Myasthenia gravis is a chronic autoimmune disease characterized by weakening of voluntary muscles during the day and a marked restitution of function during the night and after rest. The symptoms may worsen over days or weeks, sometimes even in a few hours, and are usually well controlled by appropriate therapy. Arachnoid cysts are congenital or acquired deformities of the arachnoid membrane and are usually too small to cause distinct clinical symptomatology. We describe a case of a 76-year-old myasthenia gravis patient with an arachnoid cyst. To the best of our knowledge this is the first reported case of these two comorbidities together.

Vorheriger Artikel May-Thurner syndrome: old acquaintance, new perspective

Nächster Artikel Role of hematological parameters in prediction of complicated appendicitis

Nacu A, Andersen JB, Lisnic V, Owe JF, Gilhus NE. Complicating autoimmune diseases in myasthenia gravis: a review. Autoimmunity. 2015;27(6):1–7.

Mao ZF, Yang LX, Mo XA, et al. Frequency of autoimmune diseases in myasthenia gravis: a systematic review. Int J Neurosci. 2011;121(3):121–9.CrossRefPubMed

Isbister CM, Mackenzie PJ, Anderson D, Wade NK, Oger J. Co-occurrence of multiple sclerosis and myasthenia gravis in British Columbia. Mult Scler. 2003;9(6):550–3.CrossRefPubMed

Somer H, Müller K, Kinnunen E. Myasthenia gravis associated with multiple sclerosis. Epidemiological survey and immunological findings. J Neurol Sci. 1989;89(1):37–48.CrossRefPubMed

Furukawa Y, Yoshikawa H, Yamada M. Neuromyelitis optica associated with myasthenia gravis: characteristic phenotype in Japanese population. Eur J Neurol. 2006;13(6):655–8.CrossRefPubMed

Kay CS, Scola RH, Lorenzoni PJ, Jarius S, Arruda WO, Werneck LC. NMO-IgG positive neuromyelitis optica in a patient with myasthenia gravis but no thymectomy. J Neurol Sci. 2008;275(1–2):148–50.CrossRefPubMed

Wang JYI, Pan J, Luo BY, Zhang YY. Temporal coincidence of myasthenia gravis and Guillain Barré syndrome associated with Hashimoto thyroiditis. Neurol Sci. 2011;32(3):515–7.CrossRefPubMed

Zhang J, Niu S, Wang Y, Hu W. Myasthenia gravis and Guillain-Barré cooccurrence syndrome. Am J Emerg Med. 2013;31(8):1264–7.CrossRefPubMed

Kung SL, Su JM, Tsai SJ, Lu TM, Chen CM. Concurrent Guillain-Barré syndrome and myasthenia gravis: the first case in Taiwan. Acta Neurol Taiwan. 2009;18(3):193–7.PubMed

10.

Oh SJ, Sher E. MG and LEMS overlap syndrome: case report with electrophysiological and immunological evidence. Clin Neurophysiol. 2005;116(5):1167–71.CrossRefPubMed

11.

Kung SL, Su JM, Tsai SJ, Lu ZM. Concurrent Guillain-Barré syndrome and myasthenia gravis: the first case in Taiwan. Acta Neurol Taiwan. 2009;18(3):193–7.PubMed

12.

Hsieh MY, Chan OW, Lin JJ, et al. Combined Guillain-Barré syndrome and myasthenia gravis. Brain Dev. 2013;35(9):865–9.CrossRefPubMed

13.

Lau KK, Goh KJ, Lee HC, Chan YT, Tan CT. The co-occurrence of serologically proven myasthenia gravis and Miller Fisher/Guillain Barré overlap syndrome: a case report. J Neurol Sci. 2009;276(1–2):187–8.CrossRefPubMed

14.

Kim JA, Lim YM, Jang EH, Kim KK. A patient with coexisting myasthenia gravis and Lambert-Eaton myasthenic syndrome. J Clin Neurol. 2012;8(3):235–7.CrossRefPubMedPubMedCentral

15.

Ekmekci O, Karasoy H, Bademkiran F, Akkus DE, Yuceyar N. Myasthenia gravis and thymomacoexisting with myotonic dystrophy type 1. Neuromuscul Disord. 2014;24(1):40–2.CrossRefPubMed

16.

Fasano A, Evoli A, Piano C, Tonali PA, Bentivoglio AR. Myasthenia gravis: an unrecognized cause of head drop in Parkinson’s disease. Parkinsonism Relat Disord. 2008;14(2):164–5.CrossRefPubMed

17.

Zis P, Argiriadou V, Temperikidis PP. Parkinson’s disease associated with myasthenia gravis and rheumatoid arthritis. Neurol Sci. 2014;35(5):797–9.CrossRefPubMed

18.

Mulder DW, Lambert EH, Eaton LM. Myasthenic syndrome in patients with amyotrophic lateral sclerosis. Neurology. 1959;9:627–31.CrossRefPubMed

19.

Naik KR, Saroja AO, Mahajan M. Unusual occurrence of amyotrophic lateral sclerosis in myasthenia gravis. Amyotroph Lateral Scler. 2012;13(5):477–8.CrossRefPubMed

20.

Turner MR, Goldacre R, Ramagopalan S, Talbot K, Goldacre MJ. Autoimmune disease preceding amyotrophic lateral sclerosis: an epidemiologic study. Neurology. 2013;81(14):1222–5.CrossRefPubMedPubMedCentral

21.

Helland CA, Lund-Johansen M, Wester K. Location, sidedness, and sex distribution of intracranial arachoid cysts in a population-based sample. J Neurosurg. 2010;113(5):934–9.CrossRefPubMed

Titel: A patient with myasthenia gravis and a large arachnoid cyst – report of a case
verfasst von: Mira Bucuk, MD, Ph.D
Iva Gasparovic, MD, Ph.D
Ivan Sonnenschein, MD, M.Sc.
Olivio Perkovic, MD, Ph.D
Publikationsdatum: 01.05.2017
Verlag: Springer Vienna
Erschienen in: Wiener klinische Wochenschrift / Ausgabe 9-10/2017
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI: https://doi.org/10.1007/s00508-017-1177-z

Springer Medizin Österreich

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9-10/2017

Austrian recommendations for the management of primary myelofibrosis, post-polycythemia vera myelofibrosis and post-essential thrombocythemia myelofibrosis: an expert statement

Tranexamic acid for treatment and prophylaxis of bleeding and hyperfibrinolysis

Patient knowledge concerning age-related macular degeneration: an AMD questionnaire

MedUni Wien Researcher of the Month Mai 2017

Veranstaltungen

Short-term effect of aflibercept on visual acuity and central macular thickness in patients not responding to ranibizumab and bevacizumab